AI-assisted source summary. Read the scope and exceptions, then follow the original documents below.
Applies to
Adults · 2023 Cochrane review of blue-light filtering spectacles
Time context
Review published August 2023; not a review of all research through 2026
Sources checked
Evidence about ordinary blue-light filtering spectacles does not cover every specialist use or all lens features. Persistent symptoms need a clinician's assessment.
What the review concluded
Cochrane's 2023 review found that blue-light filtering lenses may not reduce short-term computer-related eye strain compared with non-filtering lenses. Sleep outcomes were uncertain. The review did not find trial evidence establishing protection of macular health.
The accompanying explanation describes 17 trials with short follow-up, from less than a day to five weeks. That limits long-term conclusions. 'No convincing evidence for this claim' is different from proving every possible effect impossible.
Our buying question: is the premium for a specific optical feature or a claimed medical benefit? Ask for evidence matching that benefit and product. Do not treat this review as a reason to skip a needed prescription, UV protection or an assessment of persistent discomfort.
Original documents used for this summary. Multiple links from one publisher are not independent corroboration. Policies can change after the check date.
AI-assisted research, writing and translation by No Secrets, using the linked public documents. This is a source summary, not firsthand reporting or an independently audited investigation. No affiliate links are used in this article.
The date above records this research pass, not the date of every underlying event. The English and Chinese versions are AI-assisted summaries; the linked original controls if they differ.